Director, Global Value & Access Strategy (Cell and Gene Therapy)
Vertex Pharmaceuticals
August 10, 2026
Remote friendly (Boston, MA)
United States
Market Access
Director, T1D (T1D Market Access Lead) — Global Value and Access Strategy (GVAS)
Key Responsibilities
- Lead payer strategic planning to optimize value and access for early-stage T1D pipeline assets
- Develop and refine Market Access strategies and core Global P&R deliverables across cross-functional, cross-regional commercialization processes
- Own Global Payer Plans integrating value evidence generation, strategic pricing, value communications, and stakeholder engagement to support reimbursement and pricing
- Represent payer position to internal stakeholders and provide strategic input into commercialization and development decisions
- Support strategies using market research, environmental data, and analogs
- Inform financial forecasts
- Partner with HEOR and Global Marketing to optimize global value proposition and integrated evidence plans
- Lead capability building and thought leadership for the evolving global payer environment
- Monitor industry/competitive/product-acceptance changes and adjust Market Access plans
- Collaborate with HEOR, International P&R, Corporate Affairs, US Managed Markets, Countries, Marketing, and Clinical Development
Qualifications
- 8+ years of biotechnology/pharmaceutical industry and/or payer experience
- Strong knowledge of US and ex-US healthcare systems
- Demonstrated strategic thinking with sound pricing and market access recommendations
- Quantitative/analytical skills; knowledge of pricing & reimbursement/HEOR principles
- General experience in commercialization and drug development
- Cell and Gene Therapy experience preferred
- Strong written/oral communication; ability to present to all levels
- Ability to operate effectively in highly cross-functional, matrix teams
Education
- BA/BS in a quantitative field; advanced degree preferred
Key Responsibilities
- Lead payer strategic planning to optimize value and access for early-stage T1D pipeline assets
- Develop and refine Market Access strategies and core Global P&R deliverables across cross-functional, cross-regional commercialization processes
- Own Global Payer Plans integrating value evidence generation, strategic pricing, value communications, and stakeholder engagement to support reimbursement and pricing
- Represent payer position to internal stakeholders and provide strategic input into commercialization and development decisions
- Support strategies using market research, environmental data, and analogs
- Inform financial forecasts
- Partner with HEOR and Global Marketing to optimize global value proposition and integrated evidence plans
- Lead capability building and thought leadership for the evolving global payer environment
- Monitor industry/competitive/product-acceptance changes and adjust Market Access plans
- Collaborate with HEOR, International P&R, Corporate Affairs, US Managed Markets, Countries, Marketing, and Clinical Development
Qualifications
- 8+ years of biotechnology/pharmaceutical industry and/or payer experience
- Strong knowledge of US and ex-US healthcare systems
- Demonstrated strategic thinking with sound pricing and market access recommendations
- Quantitative/analytical skills; knowledge of pricing & reimbursement/HEOR principles
- General experience in commercialization and drug development
- Cell and Gene Therapy experience preferred
- Strong written/oral communication; ability to present to all levels
- Ability to operate effectively in highly cross-functional, matrix teams
Education
- BA/BS in a quantitative field; advanced degree preferred